Patents
Patents for C07D 249 - Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms (17,749)
07/2008
07/30/2008CN101230044A Synthesis of 4-substituted methoxy acrylate-1,2,4-triazolinones derivatives and herbicidal activity
07/29/2008US7405232 Long acting beta-2 agonists and their use as medicaments
07/29/2008US7405231 Oxidized thioether derivatives
07/29/2008CA2355711C Fungicide mixture
07/29/2008CA2205811C Multifunctional cyanate ester and epoxy blends
07/29/2008CA2175767C Adhesion receptor antagonists
07/24/2008WO2008086857A1 Triazole derivative as an hsp 90 inhibitor
07/24/2008US20080177081 Reacting 3,5-bis(2-cyanoisopropyl)toluene with a brominating reagent such as N-bromosuccinimide and 2,2'-azobis(2-methylpropionitrile) in solvent to produce 1-(bromomethyl)-3,5-bis(2-cyanoisopropyl)benzene; reacting with 1,2,4-triazole; purification, crystallization; avoids toxic solvents and reactants
07/24/2008US20080176917 Schizophrenia; bioavailability, solubility, brain penetrancy; in vivo half life; synthesis; such as 3-[3-({4-methyl-5-[4-(pentafluoro-6-sulfanyl)phenyl]-4H-1,2,4-triazol-3-yl}thio)propyl]-1-[4-(trifluoromethyl)phenyl]-3-azabicyclo[3.1.0]hexane
07/24/2008US20080176916 A-amino-n-hydroxy-acetamide derivatives
07/24/2008US20080176850 able to inhibit various mutated RTs, including K103N, Y181C and Y188L
07/24/2008DE102007002715A1 Triazolderivat Triazole derivative
07/24/2008CA2675737A1 Triazole derivative
07/23/2008EP1945705A1 Photolatent systems
07/23/2008EP1945618A2 Process for the preparation of letrozole
07/23/2008EP1945272A1 Method of scintigraphy
07/23/2008EP1389223B1 Method for producing polyisocyanates
07/23/2008CN101228137A Substituted triazole derivatives and their use as neurokinin 3 receptor antagonists
07/23/2008CN101225074A Synthesis of compound containing aryl ether triazole
07/23/2008CN100404536C Triazolopyrimidine derivatives as glycogen synthase kinase 3 inhibitors
07/17/2008WO2008065123A3 Polymorphic forms of deferasirox ( icl670a)
07/17/2008WO2008065123A2 Polymorphic forms of deferasirox ( icl670a)
07/17/2008US20080171881 Method for Producing Organic Compound and Method for Decomposing Compound Having Dicarboximide Skeleton
07/17/2008US20080171777 Biaryl substituted triazoles as sodium channel blockers
07/17/2008US20080171692 Substituted amides
07/17/2008US20080171662 Aminocarbonyl-Substituted Thiensulfonylamino(Thio)Carbonyl-Triazolin(Ethi)Ones, Processes For Their Preparation And Their Use
07/16/2008EP1943234A1 Triazole compounds as lipoxygenase inhibitors
07/16/2008EP1943224A2 Estrogen receptor modulators
07/16/2008EP1943004A2 Ruthenium-catalyzed cycloaddition of alkynes and organic azides
07/16/2008EP1942904A2 Cholesteryl ester transfer protein inhibitors
07/16/2008CN100402507C Benzotriazole compound containing sulfur, and its preparing method
07/16/2008CN100402499C 2-iminopyrrolidine derivatives
07/15/2008US7399537 Organic electroluminescence device and phenylenediamine derivative
07/10/2008WO2008083356A1 Substituted triazoles useful as axl inhibitors
07/10/2008WO2008082198A1 Antifungal triazole derivatives, method for the preparation thereof and pharmaceutical composition containing same
07/10/2008US20080167357 Azabicyclo (3.1.0) Hexane Derivatives Useful as Modulators of Dopamine D3 Receptors
07/10/2008CA2710051A1 Substituted triazoles useful as axl inhibitors
07/09/2008EP1940811A1 Heterocyclic compounds with carboxyl isostere groups and their use for the treatment of cardiovascular diseases
07/09/2008EP1940807A1 Carbamoylbenzotriazole derivatives as inhibitors of lipases and phospholipases
07/09/2008EP1940806A2 A process for the preparation of pure anastrozole
07/09/2008CN100400520C Method for extracting methyl o-phenylendiamine from TDI organic residue and synthesizing TTA using same
07/09/2008CN100400487C Glucocorticoid receptor modulators
07/08/2008WO2008083353A1 Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as axl inhibitors
07/08/2008CA2710043A1 Bicyclic aryl and bicyclic heteroaryl substituted triazoles useful as axl inhibitors
07/03/2008WO2007137066A3 HETEROCYCLIC INHIBITORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE I AND METHODS OF USING THE SAME
07/03/2008US20080161325 e.g. N1-[3-amino-4-(3,5-difluorophenyl)-2-hydroxybutyl]-3-(butylsulfonyl)-N1-(3-ethylbenzyl)-D-alaninamide dihydrochloride; inhibitors of amyloid beta-secretase enzyme; neurodegenerative diseases: Alzheimer's, Parkinson's diseases, Down's syndrome
07/03/2008US20080156227 Benzotriazole compound other than 2-(2-hydroxy-3- alpha -cumyl-5-tert-octylphenyl)-2H-benzotriazole plus a hindered amine, a phosphite and a phenolic anti-oxidant compound; storage stability without using any volatile solvent
07/03/2008CA2672727A1 Sphingosine-1-phosphate receptor agonist and antagonist compounds
07/02/2008EP1939203A2 Inhibitors of human phosphatidyl-inositol 3-kinase delta isoform
07/02/2008EP1939183A1 Novel nitrogenated heterocyclic compound
07/02/2008EP1937638A1 Methods of treating amyloidosis using aryl-cyclopropyl derivative aspartyl protease inhibitors
07/02/2008EP1501808B1 Tachykinin receptor antagonists
07/02/2008EP1496838A4 Substituted amides
07/02/2008CN101213657A Epoxy bleedout-preventing agent
07/02/2008CN100398612C Azo compound, aqueous dye solutions containing the same, inks and use thereof
07/02/2008CN100398536C Compounds, methods and formulations for the oral delivery of a glucagon like peptide (glp)-1 compound or an melanocortin 4 receptor (mc4) agonist peptide
07/01/2008US7393873 Arylsulfonamide derivatives
06/2008
06/26/2008WO2008077138A1 3-benzofuranyl-4-indolyl maleimides as potent gsk3 inhibitors for neurogenerative disorders
06/26/2008WO2008076225A2 Non-nucleoside reverse transcriptase inhibitors
06/26/2008WO2008076223A1 Non-nucleoside reverse transcriptase inhibitors
06/26/2008WO2008075955A2 Process for the preparation of 1,4,5-trisubstituted triazoles and 3,4,5-trisubstituted triazoles
06/26/2008WO2008075152A1 1- [4- (sulfonyl) -phenyl] -5- (benzyl) -ih-i, 2, 4-triazol derivatives as inhibitors of carbonic anhydrase for treating glaucoma or ocular hypertension
06/26/2008WO2008034644A3 Process for making anastrozole
06/26/2008US20080153892 1-(Urea-, thiourea- and cyanoguanidine-methylene)benzyl)imidaoles, treatment of neuronal disorders, especially Alzheimer's disease, Down Syndrome, Parkinson's disease and Huntington's disease
06/26/2008US20080153836 1H-Quinazoline-2,4-Diones
06/26/2008US20080153812 Novel compounds
06/26/2008CA2673368A1 3-benzofuranyl-4-indolyl maleimides as potent gsk3 inhibitors for neurogenerative disorders
06/26/2008CA2673093A1 Non-nucleoside reverse transcriptase inhibitors
06/25/2008EP1935869A1 Retinoids for the treatment of emphysema
06/25/2008EP1934188A2 Alpha, alpha`-dihydroxy ketone derivatives and use thereof as uv filter
06/25/2008CN101208312A Method of synthesis of anastrozole and purification of one of its intermediate
06/25/2008CN101208088A Phenylalkyl substituted heteroaryl devivatives
06/25/2008CN101208082A Niacin receptor agonists, compositions containing such compounds and methods of treatment
06/25/2008CN101205216A Benzotriazole ammonium salts, preparation and uses thereof
06/25/2008CN100396679C Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase
06/24/2008US7390835 Aralkyl amines as cannabinoid receptor modulators
06/19/2008WO2008073461A2 Ion channel modulators
06/19/2008US20080146632 Fc Receptor Modulating Compounds and Compositions
06/19/2008US20080146620 Dibenzylamine Compounds and Pharmaceutical Use Thereof
06/19/2008US20080145946 Impurity of anastrozole intermediate, and uses thereof
06/18/2008EP1932833A1 Nitrogenated heterocyclic compound and pharmaceutical composition comprising the same
06/18/2008EP1931647A2 Selected cgrp antagonists, methods for the production thereof and their use as medicaments
06/18/2008EP1931646A2 Selected cgrp antagonists, a method for the production thereof and use in the form of drugs
06/17/2008US7387668 Azo compound, aqueous dye solutions containing the same, inks and use thereof
06/17/2008CA2286772C Fungicide active substance combinations
06/12/2008US20080139599 e.g. 4-[6-(5-methyl-2-phenyloxazol-4-ylmethoxy)-1-oxoindan-5-yl]benzoic acid; antidiabetic and antilipemic agent, obesity; atherosclerosis; coupling benzene derivatives folowed by hydration and alkylation
06/12/2008US20080139560 Ion Channel Modulators
06/11/2008EP1928846A2 Triazole compounds that modulate hsp90 activity
06/11/2008EP1928822A1 Violet laser excitable dyes and their method of use
06/11/2008EP1449836B1 Low dusting crystal transformations of 2, 2'-methylenbis 4-(1,1,3,3-tetramethylbutyl)-6-benzotriazolylphenol and mixture thereof, method for preparing them, and ultraviolet absorbent using the same
06/11/2008EP1180107B1 Novel ruthenium metal alkylidene complexes coordinated with triazolylidene ligands that exhibit high olefin metathesis activity
06/10/2008US7385054 For use as contrast media; x-ray diagnosis and magnetic resonance imaging
06/10/2008CA2296665C Triazolo[4,5-d]pyrimidine derivatives as anti-thromobotic agents
06/05/2008WO2008014811A8 PROCESS FOR THE PREPARATION OF ε-ALKOXYCARBONYLLYSINES AND THEIR ANALOGUES
06/05/2008WO2007018431A3 Triazole-containing releasable linkers and conjugates comprising the same
06/05/2008US20080132556 3-hydroxymethyl-4hydroxy-phenyl- derivatives for the treatment of respiratory diseases
06/05/2008US20080132524 Ortho-heterocyclic substituted aryl amides for controlling invertebrate pests
06/05/2008US20080132507 Hydrazide Derivatives
06/05/2008US20080132506 Anti-inflammatory medicaments
06/05/2008US20080132459 Inhibitors of Histone Deacetylase
1 ... 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 ... 178